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CC BY-NC-ND license (http://creativeBackground: Despite the high vaccination coverage in Taiwan, sporadic cases or small cluster
of measles still occur every year. Nevertheless, few studies provided information about the
serostatus for measles in recent years. This cross-sectional survey aimed to establish the ser-
oepidemiologic data of measles among elementary school children in New Taipei City, Taiwan
during 2012e2013.
Methods: A multistage stratified sampling design using 14 variables was employed to obtain
samples. All selected schoolchildren were bled for the serologic tests of measles by both che-
miluminescence immunoassay (CLIA) and enzyme immunoassay (EIA).
Results: A total of 856 schoolchildren from 14 schools were recruited in this study. Among
these individuals, the overall seropositive rates for measles were 82.24% and 92.17% by the
Liaison and NovaLisa assays, respectively. For schoolchildren in each grade, the seropositive
rates were > 90% for Grade 1, and then decreased gradually to 70e80% for Grade 6
(p < 0.001 for both methods). A decay of measles-specific immunoglobulin G titers was also
observed with the maximum drop between Grade 1 and Grade 2 (declining trend of
p < 0.001 for both).t of Pediatrics, Chang Gung Children’s Hospital, Number 5, Fu-Hsin Street, Kweishan 333, Taoyuan,
ail.com (Y.-C. Hsieh), ychuang@cgmh.org.tw (Y.-C. Huang).
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562 Y.-C. Lin et al.Conclusion: Although the seropositive rate of measles was > 90% for Grade 1, the rate for
Grade 6 was only in the range of 70e80%, which may be a challenge to prevent outbreaks of
measles in the future and should be monitored meticulously.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Measles is an acute viral disease which is highly infectious in
nature. It brings about a large body of illnesses, including
fever, rash, conjunctivitis, diarrhea, pneumonia, encepha-
litis, and even death. In Taiwan, measles occurred
epidemically with a 2-year cyclic fluctuation in the pre-
vaccination era.1 To diminish the burden of this disease,
the Taiwanese government has been making a great effort
by the use of measles-containing vaccines over the past 3
decades.
In Taiwan, the live attenuated measles vaccine (Schwarz
strain) was first licensed for use in 1968 and a nationwide
mass vaccination program with a two-dose schedule for
children aged 9 months and 15 months was started in 1978.
In January 1988, the immunization program was switched to
a single dose of vaccine at 12 months of age, but was soon
changed back to a two-dose schedule administered at 9
months and 15 months of age in May 1988, because of an
outbreak of measles.2 This strategy was continuously
employed until 1991. Since 1992, the second dose of mea-
sles vaccine at 15 months of age was substituted with a
measles, mumps, and rubella (MMR) vaccine on account of
the policy for the elimination of measles, congenital rubella
syndrome, poliomyelitis, and neonatal tetanus. Further-
more, a catch-up campaign with one dose of MMR vacci-
nation targeting school students aged 7e13 years was
conducted from 1992 to 1994. Since 2001, giving the second
dose of MMR vaccine when first attending primary school
was started. Another catch-up campaign was carried out for
children aged 8e13 years from 2001 to 2004 due to out-
breaks.3 Since 2006, the first dose of measles vaccine was
ceased, and a schedule of two doses of MMR vaccine was
adopted: one at 12e15 months of age and the other at
elementary school entry. However, the schedule for the
first MMR vaccine was changed to 12 months of age in April
2009 in response to a reappearance of measles resulting
from imported cases during the period of November 2008 to
February 2009.4,5 The second dose of MMR vaccine was
switched to be given to children aged 5e6 years before they
entered primary school, in September 2012.
According to data from the Taiwan Centers for Disease
Control, the coverage rate for the first dose of measles
vaccine reached 97.31% by 2012. However, domestic cases
as well as imported cases of measles were still identified in
low numbers every year in Taiwan. Seroepidemiologic data
were very beneficial in understanding the epidemiology of
infectious disease and determining the control strategy.
Although seroprevalence for measles in Taiwan was previ-
ously well documented, the childhood serostatus was no
longer well understood as measles became a sporadicdisease, especially in the past 3 years. Therefore, we car-
ried out this survey to investigate the immunity status
against measles in elementary school students in Northern
Taiwan. The survey will be the pilot study of an ongoing
nationwide study, and will be provided as the reference for
a national immunization program.
Materials and methods
Ethics statement
The study proposal was reviewed and approved by the
Institutional Review Board at Chang Gung Memorial Hospi-
tal, Taoyuan, Taiwan in 2012. Informed consents were ob-
tained from all participants as well as their guardians. All
informed consents were in the written form.
Study populations and selection of participants
A cross-sectional survey of measles-specific immunoglob-
ulin (Ig)G antibody in the population of elementary
schoolchildren in New Taipei City was conducted from
September 2012 to June 2013. New Taipei City comprises 29
administrative districts and is the second largest special
municipality in Northern Taiwan. A total of 225,234 pupils
resided in this city, which accounted for 16.5% of all pri-
mary school children in Taiwan in 2012. A multistage
stratified method with probability proportional to size
sampling was employed to obtain samples. The 29 admin-
istrative districts of New Taipei City were classified into five
strata based on 14 variables, which included four de-
mographic variables [population density (persons/km2),
proportion of population aged > 65 years, < 15 years, and
< 6 years], four socio-educational variables (number of
physicians, nursing staff, low-income households, and near-
poor households/10,000 people), and six medical facilities’
variables (nursing staff/10,000 people, medical personnel/
10,000 people, all staff in health centers/10,000 people,
number of colleges or universities/10,000 people, propor-
tion of agriculture population, and proportion of population
with a college degree or above). From each stratum,
elementary schools were selected as the primary sampling
unit, and then classes were selected as the second sampling
unit. One class was drawn from each grade in a sampled
school, that is, a total of six classes were drawn from each
sampled school. Students were selected at the final stage
of the sampling scheme. Selected students were bled for
the serologic tests of measles. All participants were mani-
festly healthy without acute illness as blood drawing. Past
medical histories were obtained by a questionnaire from
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reliably obtained by vaccination records.
Determination of measles-specific antibodies
Sera were stored at 20C before measurements. Two
different methods were employed to determine measles-
specific IgG: (1) chemiluminescence immunoassay (CLIA;
Liaison, DiaSorin, Italy); and (2) enzyme immunoassay (EIA;
NovaLisa, NovaTec, Dietzenbach, Germany). Sera were
tested following the directions of the manufacturers. The
results were interpreted based on the respective manufac-
turer’s instructions. For the Liaison method, the antibody
titers were calculated in arbitrary unit (AU)/mL. Samples
with an antibody titer of > 16.5 AU/mL were classified as
positive, a titer between 13.5 AU/mL and 16.5 AU/mL was
grouped as equivocal, and a titer of < 13.5 AU/mL was
considered as negative. With respect to the NovaLisa assay,
antibody titers were acquired using NovaTec Units (NTU). An
NTU was defined as patient (mean) absorbance value  10/
cut-off value. The results were considered positive for titers
> 11 NTU. Titers< 9 NTU and in the range of 9e11 NTU were
negative and equivocal, respectively.
Statistical analysis
Measles-specific antibody titers were presented as geo-
metric mean titers (GMT). Differences in seropositiveTable 1 Seroprevalence among 856 primary school children in
School (administrative district) Schoolchildren, n
1st stratum 517
Zhong-Shan (Ban-Qiao) 89
San-Zhong (San-Zhong) 92
Zhong-Gang (Xin-Zhuang) 86
Lu-Zhou (Lu-Zhou) 77
Ji-Mei (San-Zhong) 89
Ju-Guang (Ban-Qiao) 84
2nd stratum 109
Cheng-Fu (San-Xia) 59
Xin-Xing (Dan-Shui) 50
3rd stratum 66
Jin-Mei (Jin-Shan) 35
Jin-Long (Xi-Zhi) 31
4th stratum 140
Gan-Yuan (Shu-Lin) 70
Wu-Gu (Wu-Gu) 70
5th stratum 24
Shi-Ding (Shi-Ding) 12
Shuang-Xi (Shuang-Xi) 12
Total 856
a The five strata were classified according to 14 variables (see text)
CLIA Z chemiluminescent immunoassay; EIA Z enzyme immunoassay
b The p values for seropositivity among 14 schools were p Z 0.25 and
c The p values for seropositivity among five strata were p Z 0.86 and
d A p value < 0.001 for seropositive rate between the two assays.percentages between different groups and the two assays
were tested by the Chi-square test. The unpaired t test was
used to compare the statistic deviances between GMT
levels in different grades. The trend of decreasing GMTs
was assessed by a linear regression method. Data analyses
were performed using SPSS software version 17.0 (SPSS Inc.,
Chicago, IL, USA). A p value < 0.05 was considered statis-
tically significant.Results
Selected schools and the number of individuals in each
stratum are shown in Table 1. In total, 856 schoolchildren
from 14 schools were recruited and bled for the serologic
tests of measles; 416 (48.5%) were male. From each school,
the difference of seropositivity or sex distribution was not
statistically apparent. There was a statistically significant
difference in seropositivity among five strata by the Nova-
Lisa method (p Z 0.03), but not by the Liaison assay
(p Z 0.86). When measured by the Liaison method, a total
of 704 (82.24%) samples were positive for measles-specific
IgG, whereas 789 (92.17%) were seropositive when the
NovaLisa assay was used (Table 1). A statistically significant
difference was observed in the seropositive rate between
the two assays (p < 0.001).
Grade-specific measles seroprevalence and the change
of GMTs are shown in Fig. 1. When tested by the Liaison
assay, the seropositive rate was 94.96% for Grade 1 butfive strataa
Sex (M/F) Positive, n (%)
Liaison
(CLIA)
NovaLisa (EIA)
0.99 429 (82.98) 486 (94.00)
0.82 67 (75.28) 84 (94.38)
0.96 79 (85.87) 88 (95.65)
0.83 72 (83.72) 81 (94.19)
1.2 65 (84.42) 73 (94.81)
1.23 70 (78.65) 83 (93.26)
1 72 (90.48) 77 (91.67)
0.85 89 (81.65) 92 (84.40)
0.64 46 (77.97) 47 (79.66)
1.17 43 (86.00) 45 (90.00)
0.61 52 (78.79) 62 (93.94)
0.67 30 (85.71) 34 (97.14)
0.55 22 (70.97) 28 (90.32)
0.94 115 (82.14) 127 (90.71)
1 54 (77.14) 61 (87.14)
0.89 61 (87.14) 66 (94.29)
2 19 (79.17) 22 (91.67)
5 10 (83.33) 11 (91.67)
1 9 (75.00) 11 (91.67)
0.95 704 (82.24) 789 (92.17)
.
.
p Z 0.07 by the Liaison and NovaLisa assays, respectively.
p Z 0.03 by the Liaison and NovaLisa methods, respectively.
AB
Figure 1. Grade-specific seropositivity and geometric mean titers of measles among 856 schoolchildren by (A) the Liaison assay
and (B) the NovaLisa assay. The p values for declining seropositivity and geometric mean titers (GMTs) by both assays were all
p < 0.001.
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seroprevalence decreased gradually to a nadir of 70.63% for
Grade 6. Similarly, seropositivity determined by the Nova-
Lisa assay also had a declining tendency from 100% for
Grade 1 to 81.12% for Grade 6 (p < 0.001). In addition, the
number of schoolchildren with equivocal serostatus
increased over time, either tested by the Liaison or the
NovaLisa assay. Similar to seroprevalence, both assays also
showed a decay of measles-specific IgG titers (both p for
declining trend < 0.001) with the maximum drop between
Grade 1 and Grade 2 (both p < 0.001).
Among 856 participants, 24 had an unclear vaccination
status, all but one of whom had received at least one dose
of MMR vaccine, and were excluded when the association
between seroprevalence and vaccination doses was further
analyzed. A total of 798 (93.2%) received two doses of
measles vaccine. Participants with two-dose vaccination
had a significantly higher seropositive rate than those whoonly received one dose of MMR vaccine (2 doses, 92.5% vs. 1
dose, 82.4 by NovaLisa, pZ 0.047; and 2 doses, 82.8% vs. 1
dose, 64.7 by Liaison, p Z 0.001). The comparisons of
seropositivity between the two different methods accord-
ing to vaccination doses are displayed in Table 2.Discussion
This study revealed an overall anti-measles IgG seropositive
rate of 82.3e92.2% via two different serological tests in the
population of elementary school students in New Taipei
City in Taiwan. Even though both the Liaison and NovaLisa
assays disclosed seropositive rates of measles > 90% for
Grade 1, the rates for Grade 6 were only in the range of
70e80%.
The difference in the seropositivity rates between the
tests by Liaison CLIA and NovaLisa EIA was statistically
Table 2 The comparisons of seropositivity between
enzyme immunoassay (EIA) and chemiluminescent immu-
noassay (CLIA), according to measles, mumps, and rubella
(MMR) vaccination status
Vaccination doses 2 (n Z 798) 1 (n Z 34) p
Positive,
n (%)
EIA
(NovaLisa)
738 (92.5) 28 (82.4) 0.032
CLIA
(Liaison)
662 (82.8) 22 (64.7) 0.007
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even greater, sensitivity and specificity in serologically
diagnosing a variety of infectious diseases when compared
to traditional EIAs.6e11 Liaison measles IgG is a new semi-
qualitative, fully automated method for determination of
measles-specific IgG, and the sensitivity and specificity
provided by the manufacturer were 94.7% and 97.4%,
respectively. To the best of our knowledge, almost all
studies use conventional EIA to measure specific IgG for
measles. In the literature to date, only two studies
employed this new automated Liaison CLIA to determine
measles IgM, in which diagnostic performances of Liaison
measles IgM were excellent.7,8 It is hard to distinguish
which method is more sensitive or specific, but the result of
a seroprevalence of 82.24% revealed by the Liaison assay is
lower than expected, considering that all participants in
our study received a second dose of MMR vaccine just
before or at elementary school entry. Further investigation
to resolve this question is warranted.
Although measles-specific IgG titers were at a high level
for Grade 1, antibody titers declined rapidly at Grade 2
from 171.05 AU/mL to 102.55 AU/mL by the Liaison method
and from 29.99 NTU to 24.5 NTU by the NovaLisa method,
respectively. In agreement with our findings, other research
observed a rapid drop of the antibody level within the 1st
year of vaccination.12 Since a nationwide childhood immu-
nization program was implemented in 1978, the incidence
of measles has declined rapidly in Taiwan. From 2000 to
2013, the incidence of measles was low, varying from
0 people/year to < 3/1,000,000 people/year (Taiwan
Center for Disease Control). As a result, participants in the
present study had a low possibility of exposure to wild
measles virus and got immunity mainly from vaccination. In
our survey, we found a declining seropositivity among pri-
mary school students despite the fact that there was
somewhat of a discrepancy in the seroprevalence examined
by two measurements. The seropositive rate significantly
declined to a nadir of 70e80% for Grade 6, whereas
schoolchildren with antibody titers in the equivocal range
increased gradually as their grade increased. These findings
presumably reflected a waning vaccine-evoked immunity
with increasing age. Without a natural booster of measles,
a rapid decay of vaccine-induced antibody titers in the
Taiwanese population was also reported in several stud-
ies.12e14. It appeared as though immunity obtained from
natural infection provided longer lasting protection. In two
previous measles seroepidemiological studies in Taiwan,
the seroprevalence in the population born before 1978
was in the range of 95e100%.2,15 Another study in Taiwan
reported that infection-induced immunity can even belifelong. According to the study, a high level of seropositive
rate > 95% remained in people > 65 years old.12
A two-dose regime of MMR vaccination was generally
considered appropriate and has been introduced into many
countries to eliminate measles infection successfully.16e19
Our study also showed that individuals with two-dose
vaccination had a significantly higher seropositive rate
than those who only received one dose of MMR vaccine.
However, the seropositive rate in Asian countries was sub-
stantially lower when compared to Western countries. In
addition to a seropositive rate of 70e80% for Grade 6 stu-
dents in our study, a study conducted in southern mainland
China in 2008 revealed that 84.4% of the group aged 2e3
years old were seropositive, whereas the seropositivity
decreased to 58.8% in the 15e29-year-old group, despite
two dose vaccination coverage data being reported as high
(> 90%) since 1986.20 In Korea, a survey revealed that the
seropositive rate was 75.3% in the population aged 11e13
years old.21 A cohort study in Finland, however, found that
the seropositive rate in vaccinees for MMR was 95% after the
20-year follow-up.22 Similarly, in a national serosurvey in
the United States, the rate of measles seropositivity in the
population overall was as high as 95.9% during 1999e2004.23
Race difference may play a role in this seroprevalent
discrepancy and should be taken into consideration in
making vaccination plans.
Measles was thought to be a highly contagious disease
with an estimated prevaccination reproductive number in
the range of 4.78 to 8.0 in Taiwan.24 Hence, a seropreva-
lence of about 95% in the population was presumed to
interrupt measles transmission.25 Although several studies
delineated that clinically vaccinees with undetectable or
low antibody titers may not necessarily be susceptible to
symptomatic measles infection because immune memory
and cellular immunity also had an influence against measles
infection,26e28 this may be a challenge to prevent out-
breaks of measles in the future, since immunity prevalence
did not reach the requirement for Grade 6 students. This
population is potentially at risk of infection with measles
and then plays a role in transmitting the disease. A booster
vaccination has been reported to be useful in decreasing
the proportion of vaccinees with low antibody titers.29 A
revaccination approach for schoolchildren of Grade 5 or 6
deserves further investigation but might not be a matter of
great urgency, because the incidence of measles in Taiwan
has been low in recent years.
The present study had several limitations. First,
although we employed a multilevel design using 14 vari-
ables to minimalize selecting bias, our participants may not
accurately represent all schoolchildren nationwide. Sec-
ond, serologic results can be confounded by previous
measles infection. All participants were not on the list of
reporting cases and we used questionnaires to obtain the
past medical histories from all schoolchildren. Modified
measles can be difficult to diagnose and the questionnaires
are still not a thoroughly reliable method. Therefore, we
cannot completely exclude the possibility of getting mea-
sles before, although the chance was very low. Further-
more, someone may question the results of seroprevalence
because there was an inconsistency between the two as-
says. Indeed, we did not put much effort into analyzing
which assay had a better diagnostic performance in this
566 Y.-C. Lin et al.study. Nevertheless, the fact that there was a decay of
seropositivity was convincing enough, because both of the
assays disclosed the same tendency.
In conclusion, the present survey demonstrated a
seroepidemiologic profile for measles in elementary school
students in Northern Taiwan. A low seroprevalence, around
70e80%, was apparent for schoolchildren above Grade 5
and two-dose vaccines had a higher seropositivity than one-
dose vaccines. Our findings may provide guidance for na-
tional medical authorities in determining a vaccination
strategy to reach the goal of measles elimination and also
point out that the seroepidemiologic status for measles
should be monitored meticulously in the future.
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